跳至主要内容
临床试验/CTRI/2021/09/036230
CTRI/2021/09/036230尚未招募4 期

Effectiveness and safety of topical autologous platelet-rich-fibrin-membrane with total-contact-castversus perilesional injectable autologous platelet-rich-plasma therapy with total-contact-cast introphic ulcer due to leprosy: randomised-controlled-trial

BANKURA SAMMILANI MEDICAL COLLEGE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age more than 18 years up to 80 years.
  • 2. Leprosy patients who are treatment-naive for leg ulcer of either sex.
  • 3. Clinically diagnosed trophic ulcer due to leprosy located on the plantar, medial, or lateral aspect of the foot (including all toe surfaces); and wound area (length x width) measurement <10 cm2.

排除标准

  • 1. Pregnant and lactating women.
  • 2. Patients with clinically diagnosed arterial or venous ulcer on the
  • leg or foot.
  • 3. Concomitant immune defect, heart disease, renal failure,
  • malignancy.
  • 4. Patients with psychiatric disorders.
  • 5. Participation in any clinical trial in last 3 months.
  • 6. Non-consenting patients.

研究者

相似试验